This content is unpublished, click the edit tab and check "Published" on the bottom of the form.
08.
10.15
14:16
Close share menu
Results from ZINBRYTA ™ (Daclizumab high-yield process) phase 3 DECIDE study highlight efficacy compared to interferon beta-1a, published in the New England Journal of medicine and presented at ECTRIMS